Lina Abdel-Halim

Artiklar

Journal article: RESPIRATORY MEDICINE. 2024;232:107744
Five sessions of hyperbaric oxygen for critically ill patients with COVID-19-induced ARDS: A randomised, open label, phase II trial
Kjellberg A; Douglas J; Pawlik MT; Hassler A; Al-Ezerjawi S; Bostrom E; Abdel-Halim L; Liwenborg L; Jonasdottir-Njastad A-D; Kowalski J; Catrina S-B; Rodriguez-Wallberg KA; Lindholm P
Article: JOURNAL OF CLINICAL MEDICINE. 2023;12(14):4850
COVID-19-Induced Acute Respiratory Distress Syndrome Treated with Hyperbaric Oxygen: Interim Safety Report from a Randomized Clinical Trial (COVID-19-HBO)
Kjellberg A; Douglas J; Hassler A; Al-Ezerjawi S; Bostrom E; Abdel-Halim L; Liwenborg L; Hetting E; Njastad ADJ; Kowalski J; Catrina S-B; Rodriguez-Wallberg KA; Lindholm P
Article: BMJ OPEN. 2022;12(11):e061870
Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial
Kjellberg A; Abdel-Halim L; Hassler A; El Gharbi S; Al-Ezerjawi S; Bostrom E; Sundberg CJ; Pernow J; Medson K; Kowalski JH; Rodriguez-Wallberg KA; Zheng X; Catrina S; Runold M; Stahlberg M; Bruchfeld J; Nygren-Bonnier M; Lindholm P
Article: BMC INFECTIOUS DISEASES. 2022;22(1):108
Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus
Hedberg P; Johansson N; Ternhag A; Abdel-Halim L; Hedlund J; Naucler P

Preprint: MEDRXIV. 2022
Hyperbaric Oxygen for Treatment of Long COVID Syndrome (HOT-LoCO); Protocol for a Randomised, Placebo-Controlled, Double-Blind, Phase II Clinical Trial
Kjellberg A; Abdel-Halim L; Hassler A; Gharbi SE; Al-Ezerjawi S; Boström E; Sundberg CJ; Pernow J; Medson K; Kowalski J; Rodriguez-Wallberg K; Zheng X; Catrina S-B; Runold M; Ståhlberg M; Bruchfeld J; Nygren-Bonnier M; Lindholm P
Preprint: RESEARCH SQUARE. 2022
COVID-19 induced acute respiratory distress syndrome treated with Hyperbaric Oxygen: Interim safety report from a multicenter, randomised, open-label phase II clinical trial (COVID-19-HBO)
Kjellberg A; Douglas J; Hassler A; Al-Ezerjawi S; Boström E; Abdel-Halim L; Liwenborg L; Hetting E; Jonasdottir-Njåstad A-D; Kowalski J; Catrina S-B; Rodriguez-Wallberg KA; Lindholm P